Trial Profile
A Placebo-Controlled, Phase 1, Single and Multiple IV Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of C326 in Adults With Crohn's Disease
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs AMG 220 (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- Sponsors Avidia
- 30 Sep 2009 New trial record.